Specifications & Handling:

Product DataSynonymsPropertiesApplication SetSpecificityCrossreactivityQuantitySensitivityRangeSample TypeAssay TypeDetection TypeProduct TypeShipping and HandlingShippingShort Term StorageLong Term StorageHandling AdviceUse/StabilityDocumentsManualMSDSRelated Products

ACRP30; AdipoQ; apM1; GBP28; Adipocyte Complement Related Protein of 30kDa

Quantitative ELISA

Detects mouse adiponectin. Does not cross-react with human adiponectin, rat adiponectin, mouse resistin, mouse RELM-β or mouse leptin.

Mouse

1 x 96 wells2 x 96 wells (Twin Plex)

50pg/ml

0.125 to 8ng/ml

Cell Culture Supernatant, Plasma, Serum

Sandwich

Colorimetric

Kit

BLUE ICE

+4°C

+4°C

After standard reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Plate and reagents should reach room temperature before use.

12 months after the day of manufacturing. See expiry date on ELISA Kit box.

Download

Download

Adiponectin (mouse) (rec.) (BULK) Adiponectin (human) ELISA Kit

Description:

Adiponectin [ACRP30; AdipoQ] is a promising biomarker of insulin resistance and type 2 diabetes mellitus (T2DM) but also as a potential target for management of the metabolic syndrome. It is a very robust marker that is not prone to degradation or acute inflammatory challenges, is present in relatively high concentrations in the peripheral circulation, and can be collected by a variety of methods. The benefits of using adiponectin assays in clinical settings include, (a) prediction of risk of diabetes and metabolic status and (b) providing a tool to monitor metabolic improvements. Adiponectin exerts anti-atherogenic and anti-inflammatory properties and may be important as a biomarker for obesity-related cardiovascular disease (CVD). New findings showed urinary adiponectin excretion as an independent new biomarker of microvascular and macrovascular damage in T2DM and suggested it as a very promising tool for early cardiovascular disease risk assessment. Adiponectin serum level was also described as a good biomarker of colorectal adenoma, this being related to the positive correlation between obesity and increased risk of cancer at various sites (colorectal, breast, prostate and endometrium).